Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1703-1709
Published online before print March 12, 2007, doi: 10.1161/CIRCULATIONAHA.106.659706
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/13/1703    most recent
CIRCULATIONAHA.106.659706v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garrigue, S.
Right arrow Articles by Lévy, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garrigue, S.
Right arrow Articles by Lévy, P.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Pacemakers and Implantable Defibrillators
*Sleep Apnea
Related Collections
Right arrow Pacemaker
Right arrowRelated Article

(Circulation. 2007;115:1703-1709.)
© 2007 American Heart Association, Inc.


Arrhythmia/Electrophysiology

High Prevalence of Sleep Apnea Syndrome in Patients With Long-Term Pacing

The European Multicenter Polysomnographic Study

Stéphane Garrigue, MD, PhD*; Jean-Louis Pépin, MD, PhD*; Pascal Defaye, MD; Francis Murgatroyd, MD; Yann Poezevara, MS; Jacques Clémenty, MD; Patrick Lévy, MD, PhD

From the Department of Cardiac Electrophysiology and Clinical Pacing Hôpital, University of Bordeaux and Grenoble, Grenoble, France (S.G., P.D., J.C.); Inserm ERI 17, Sleep Laboratory and Hypoxia Pathophysiology (HP2) Laboratory, University Hospital and Joseph Fourier University, Grenoble, France (J.-L.P., P.L.); Department of Cardiac Electrophysiology and Clinical Pacing, Papworth Hospital, Cambridge, UK (F.M.); and ELA Medical, Clinical Research Department, CA La Boursidière, Le Plessis-Robinson, France (Y.P.)

Correspondence to Professor Patrick Lévy, Laboratoire d’Exploration Fonctionnelle Cardio-Respiratoire, CHU, Grenoble, 38043 France. E-mail PLevy{at}chu-grenoble.fr

Received August 22, 2006; accepted January 19, 2007.

Background— Cardiovascular diseases leading to pacemaker implantations are suspected of being associated with a high rate of undiagnosed sleep apnea syndrome (SAS). We sought to determine the prevalence and consequences of SAS in pacemaker patients according to pacing indications: heart failure, symptomatic diurnal bradycardia, and atrioventricular block.

Methods and Results— Ninety-eight consecutive patients (mean age, 64±8 years) not known to have sleep apnea were included; 29 patients were paced for dilated cardiomyopathy (29%), 33 for high-degree atrioventricular block (34%), and 36 for sinus node disease (37%). All underwent Epworth Sleepiness Scale assessment and polysomnography with the pacemaker programmed to right ventricular DDI pacing mode (lower pacing rate, 50 pulses per minute). SAS was defined as an apnea-hypopnea index ≥10/h. Mean Epworth Sleepiness Scale was in the normal range (7±4), although 13 patients (25%) had an abnormal score >11/h. Fifty-seven patients (59%) had SAS; of these, 21 (21.4%) had a severe SAS (apnea-hypopnea index >30/h). In patients with heart failure, 50% presented with SAS (mean apnea-hypopnea index, 11±7) compared with 68% of patients with atrioventricular block (mean apnea-hypopnea index, 24±29) and 58% with sinus node disease (mean apnea-hypopnea index, 19±23).

Conclusions— In paced patients, there is an excessively high prevalence of undiagnosed SAS (59%). Whether treating SAS would have changed the need for pacing is unknown. Treatment effects should be further evaluated particularly because these patients are less symptomatic than typical SAS patients. In any case, SAS should be systematically searched for in paced patients owing to potential detrimental effects on their cardiovascular evolution.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2007 115: 1697. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Circulation, September 2, 2008; 118(10): 1080 - 1111.
[Full Text] [PDF]


Home page
ChestHome page
C. M. Ryan, S. Juvet, R. Leung, and T. D. Bradley
Timing of Nocturnal Ventricular Ectopy in Heart Failure Patients With Sleep Apnea
Chest, April 1, 2008; 133(4): 934 - 940.
[Abstract] [Full Text] [PDF]